We deliver insights for informed decision-making and effective navigation of the evolving market access landscape.
Value and Insights
- Early Phase Due Diligence for Asset Acquisition
- Medical and Commercial Value Assessments, Early Pipeline To Launch
- Market Shaping (Pre-approval Information Exchange Decks and Pre-approval Dossiers)
- AMCP Dossier and Economic Value Proposition
- Evidence Generation Plan Gap Assessment
- Pipeline Asset and Portfolio Assessment (Analogs, Price Bands)
- Strategic Council
Commercial Planning
- Landscape Assessments
- Patient Services Recommendations; Hub Services Vendor Request for Proposal and Evaluation and Selection
- Field Team Engagement Strategy and Planning
- Environmental Analyses and Business Planning Across Payer, Patient, Site of Care, etc.
- Annual Strategic Plan Development, including Quarterly Business Reviews
- Evaluate Data and Reporting Needs From Launch To Loss of Exclusivity
- Contract Strategy and Analysis for Contract Management and Gross to Net Implications
Stakeholder Engagement
- Payer Engagement Resources
- Health Economic Models and HEOR Field Tools
- Payer Conference Engagement Strategy and Messaging
- Hub and Specialty Pharmacy Vendor On-boarding, SOW Creation, and Contract Negotiations
- Patient Services Operational Support
- Market Access Field and Sales Training
- Field Solutions and Account Management
- Market Access KPI Monitoring Across Payers by Channel
About
Why Choose Us
Pharmaceutical companies now have a limited number of critical touch points with payers and patients to successfully achieve their reimbursement and product access objectives.